Impact of the HeartMate 3 continuous-flow left ventricular assist device in patients with small body size
Kohei Tonai(National Cerebral and Cardiovascular Center), Tomoyuki Fujita(The University of Tokyo), Ayumi Ikuta(National Cerebral and Cardiovascular Center), Osamu Seguchi(National Cerebral and Cardiovascular Center), Naoki Tadokoro(National Cerebral and Cardiovascular Center), Takashi Kakuta(National Cerebral and Cardiovascular Center), Yasumasa Tsukamoto(National Cerebral and Cardiovascular Center), Satsuki Fukushima(National Cerebral and Cardiovascular Center), Norihide Fukushima(National Cerebral and Cardiovascular Center), Takuya Watanabe(Takeda (Japan)), Satoshi Kainuma(National Cerebral and Cardiovascular Center), Naonori Kawamoto(National Cerebral and Cardiovascular Center)
Cited by 4
Related Papers
Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017)
|Circulation Journal|2019|224
Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy
|Frontiers in Cardiovascular Medicine|2022|106
IL-4 as a Repurposed Biological Drug for Myocardial Infarction through Augmentation of Reparative Cardiac Macrophages: Proof-of-Concept Data in Mice
|Scientific Reports|2017|105
Recombinant human betacellulin. Molecular structure, biological activities, and receptor interaction
|Journal of Biological Chemistry|1994|101
JCS/JSCVS 2018 Guideline on Revascularization of Stable Coronary Artery Disease
|Institutional Repositories DataBase (IRDB)|2022|73